Work

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

Year: 2018

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2018.02.016

Authors: H. Lindman, M. Andersson, J. Ahlgren, E. Balslev, A. Sverrisdottir, S.B. Holmberg, N.O. Bengtsson, E.H. Jacobsen, A.B. Jensen, J. Hansen, M.K. Tuxen, L. Malmberg, K. Villman, H. Anderson, B. Ejlertsen, J. Bergh, C. Blomqvist

Institutions: Uppsala University Hospital, Rigshospitalet, Gävle Hospital, Herlev Hospital, Stockholm South General Hospital, University Hospital of Umeå, Vejle Sygehus, Aarhus University Hospital, Västmanlands sjukhus Västerås, Karlstad Central Hospital, Örebro University Hospital, Lund University, Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancerfonden, Herlev Hospital, Karolinska Institutet

OpenAlex ID: W2789433883

FWCI: 0.227

Cites: 23

Cited by: 4

Related to: 10